Skip to main content
. 2020 Apr 10;26(7):1312–1317. doi: 10.1016/j.bbmt.2020.04.001

Table 2.

Univariate Outcomes of the Matched Population

Outcomes Fresh (N = 1080) Cryopreserved (N = 274)
n Prob (95% CI), % n Prob (95% CI), % P Value
Neutrophil recovery 1075 270
28 days 93.8 (92.3-95.1) 93.3 (90-96) .80
Platelet recovery 1076 270
100 days 88.8 (86.8-90.6) 87.7 (83.4-91.4) .62
Grade II-IV acute GVHD 1040 271
100 days 31.3 (28.5-34.1) 34 (28.5-39.8) .40
Grade III-IV acute GVHD 1040 271
100 days 9.4 (7.7-11.3) 6.3 (3.7-9.5) .07
Chronic GVHD 1077 272
1 year 30.7 (27.9-33.5) 26.8 (21.5-32.5) .22
2 years 36.4 (33.4-39.6) 29.5 (23.8-35.5) .04
Relapse/progression 1062 273
1 year 24.1 (21.6-26.8) 24.7 (19.7-30.1) .85
2 years 30.7 (27.7-33.7) 36.3 (29.9-42.9) .13
NRM 1062 273
1 year 15.8 (13.7-18.1) 16.9 (12.6-21.7) .67
2 years 19 (16.5-21.5) 22 (16.8-27.7) .32
DFS 1062 273
1 year 60 (57-63) 58.4 (52.4-64.3) .63
2 years 50.4 (47-53.7) 41.7 (35-48.6) .03
OS 1080 274
1 year 71.1 (68.3-73.8) 70.3 (64.6-75.7) .81
2 years 60.6 (57.3-63.8) 58.7 (51.9-65.4) .62